Novo Says Still Some Uncertainty on Tresiba Costs

Oct. 31 (Bloomberg) -- Novo Nordisk A/S Chief Financial Officer Jesper Brandgaard talks about the company's third-quarter profit reported today, sales forecast and the launch of its new diabetes treatment, Tresiba. He speaks from Bagsvaerd, Denmark, with Caroline Hyde on Bloomberg Television's "The Pulse." (Source: Bloomberg)

Google Search: Crystal Ball for Election Results?
12:53 - Khosla Ventures partner Keith Rabois, Braintree head of commerce Harper Reed and Bloomberg’s Tim Higgins discuss how campaigns can use Google search data with Emily Chang on “Bloomberg West.” (Source: Bloomberg)
  • Apple Said to Produce New Show Starring Dr. Dre
  • Can PayPal Commerce Stand Up to Competition?
  • How Medium Recruits High Profile Writers